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Lipid peroxidationAbstract Hexavalent chromium [Cr (VI)]-mediated oxidative stress causes severe hepatic toxicity.
This study aims to investigate the protective role of oral vitamin E administration against potassium
dichromate (K2Cr2O7)-induced hepatotoxicity. Adult male rats (Rattus norvegicus, n= 24) weigh-
ing 150–180 g were used and divided into 4 groups (n= 6 per group): the control group received
distilled water; control + vitamin E group received vitamin E (100 mg/kg b.w.); Cr group received
K2Cr2O7 (8 mg/kg b.w.), and Cr + vitamin E group received K2Cr2O7 + vitamin E. All treatments
were administered orally on a daily basis for 6 weeks.
There was a signiﬁcant accumulation of Cr in the livers of the Cr group compared with the con-
trol group. In addition, exposure to K2Cr2O7 induced signiﬁcant increases in the level of thiobar-
bituric-reactive substances (TBARS) and signiﬁcant decreases in glutathione (GSH) content and
superoxide dismutase (SOD) activity in the Cr group compared with the control group. Moreover,
livers of the Cr group showed major histological alterations, such as severe necrosis, increased lym-
phocytic inﬁltration, and a signiﬁcant decrease in the DNA content. Oral vitamin E administration
concomitant with K2Cr2O7 ameliorated all these changes and resulted in normal hepatic histolog-
ical and cellular contents. In conclusion, oral vitamin E administration has a hepatoprotective role
against K2Cr2O7-induced hepatotoxicity in rats.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Chromium (Cr) is a naturally occurring heavy metal
commonly found in the environment in two valence states:[remark 2] trivalent Cr (III) and hexavalent Cr (VI). It is widely
used in numerous industrial processes, and thus is a contami-
nant of many environmental systems (Bagchi et al., 2002). It is
commonly used in various industries (e.g., steel, alloy, cast
iron, chrome plating, paints, leather tanning, photography,
and metal ﬁnishes). However, Cr (VI) compounds have been
reported to be more toxic and carcinogenic than those of Cr
(III) because the former can pass through cell membranes
more easily than the latter (Patlolla et al., 2009). Once inside
the cell, Cr (VI) is reduced to its lower oxidation states, Cr
(V) and Cr (IV), and then to Cr (III) by low-molecular weight
molecules, enzymatic reductants, and nonenzymatic reductants
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capable of generating a whole spectrum of reactive oxygen spe-
cies (ROS), which is an important characteristic of Cr (VI)
metabolism (O’Brien et al., 2001). An excessive quantity of
ROS that is generated by these reactions can cause injury to
cellular proteins, lipids, and DNA, leading to a state known
as oxidative stress (Liu and Shi, 2001; Sugiyama, 1992; Yam-
Canul et al., 2008). Therefore, one of the most important dam-
ages caused by extraneous Cr (VI) is the massive ROS produc-
tion during Cr (VI) reduction in the cell.
However, the liver is the major organ responsible for
metabolism, detoxiﬁcation, and secretory functions in the
body. Hence, it regulates various important metabolic func-
tions in mammalian systems (Sugiyama, 1992). Cr (VI) has
been reported to cause hepatotoxicity in humans and labora-
tory animals primarily through an oxidative stress-mediated
mechanism (Laborda et al., 1986; Soudani et al., 2011; Sugiy-
ama, 1992). Exposure of rats to Cr induced oxidative stress
with an increase in hepatic malondialdehyde (MDA) levels
and a decrease in glutathione (GSH) levels. In addition, it in-
duced a parallel decrease in glutathione peroxidase (GPx)
activity and an increase in superoxide dismutase (SOD) and
catalase (CAT) activities, with a decrease of liver glycogen con-
centration and oxidative deterioration of lipids and proteins
(Garcia-Nino et al., 2013; Soudani et al., 2011). Considering
the high sensitivity of the liver to Cr (VI)-related insult, pre-
ventive intervention is a major concern.
Vitamin E has received wide attention due to its reported
hepatoprotective effects in animals, which is primarily due to
its ability to attenuate the induced oxidative stress in various
tissues by reducing MDA levels; restoring the levels of GSH,
SOD, and CAT and the recovery of impaired hepatic cells
(Bharrhan et al., 2010).
Many studies have reported the antioxidant protective
effect of vitamin E against several metals that induced hepato-
toxicity, including copper, lead, sodium ﬂuoride, cadmium,
mercury, and ferrous sulfate (Al-Attar, 2011; Chinoy et al.,
2004; Gaurav et al., 2010; Osfor et al., 2010). The protective
effect of vitamin E against Cr-induced hepatotoxicity was
reported in a study where the authors investigated the direct
protective effect of vitamin E on Cr (VI)-induced cytotoxicity
and lipid peroxidation in primary cultures of rat hepatocytes
(Susa et al., 1996). Susa et al. (1996) reported that such protec-
tive effects may be associated with the levels of nonenzymatic
instead of enzymatic antioxidants. However, this study was
conducted on primary cultures of rat hepatocytes, and to our
knowledge, no study has been conducted on the protective
effects of oral administration of vitamin E against Cr-induced
hepatotoxicity in living organisms. Therefore, the current
study aimed to determine whether oral administration of
vitamin E would have protective effects against Cr-induced
hepatic injury, oxidative stress, and hepatic structural changes
in rats.2. Materials and methods
2.1. Chemicals
Cr as potassium dichromate (K2Cr2O7) was obtained from
Sigma–Aldrich, St. Louis, MO, USA, dissolved in distilled
water to form a stock solution of 10 mg/ml, and diluted furtheraccording to the dose required per rat. Vitamin E [a-tocopheryl
acetate, natural (1 mg/ml)] was purchased from BDH, England
and was diluted in olive oil to a ﬁnal concentration of 100 mg/
ml which was used further in the experimental procedure
according to selected dose per weight of rats. All other chemi-
cals and reagents were purchased from Sigma–Aldrich, St.
Louis, MO, USA.2.2. Experimental animals
This study was conducted at the laboratories of the biology
department at King Khalid University, Abha, KSA with the
approval of the Ethics Committee of the College of Science
at King Khalid University. Furthermore, the study followed
the international guidelines for the care and use of laboratory
animals. Adult male rats (Rattus norvegicus) 6–8-week old
(150–180 g) used in this study were obtained from the experi-
mental animal unit at the faculty of science at King Khalid
University, Abha, KSA. Rats were fed standard rat pellets
and allowed ad libitum to water during acclimatization. They
were housed at a controlled ambient temperature of
25 ± 2 C and 50 ± 10% relative humidity, with a 12-h
light/dark cycle.2.3. Experimental procedure
After a 1-week adaptation period, the rats were randomly di-
vided into 4 groups of 6 rats each: the control group, received
1 ml of distilled water; control + vitamin E group, received
100 mg/kg b.w. of vitamin E; Cr group, received 8 mg/kg
b.w. K2Cr2O7; Cr + vitamin E group, received concomitant
doses of K2Cr2O7 (8 mg/kg b.w.) and vitamin E (100 mg/kg
b.w.). All treatments were orally administered on a daily basis
for 6 weeks. Dose selection and mode of administration of
both K2Cr2O7 and vitamin E were based on previous studies
(Susa et al., 1996). Six hours after the last treatment on Day
42, rats from all groups were anesthetized with light diethyl
ether. Blood samples (1 ml) were collected using a 1-ml syringe
directly from the heart using the ventricular puncture method
into plain 3-ml untreated glass tubes and were allowed to clot
for 15 min at room temperature. Samples were centrifuged at
4000 rpm for 10 min to separate and obtain the serum, which
was used to determine the serum Cr levels, then all rats were
sacriﬁced by decapitation. Parts of their livers were ﬁxed in
10% neutral-buffered formalin for histopathological and his-
tochemical analyses. Other parts of their livers were removed
and transferred to a Petri dish, where they were washed with
phosphate–buffered saline (PBS). PBS (pH 7.4) contained
0.16 mg/ml of heparin, and washes were performed to remove
any red blood cells (erythrocytes) and clots. Then the tissue
was homogenized in the appropriate buffer for determination
of the biochemical parameters.2.4. Biochemical analysis
Lipid peroxidation was estimated by measuring the thiobarbi-
turic-reactive substances (TBARS) as malondialdehyde in liver
homogenate using the method of Ohkawa et al. (1979). The
activity of superoxide dismutase (SOD) in sera was assayed
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thione (GSH) was measured using the method of (Ellman,
1959). Cr concentration was estimated in the liver tissues and
sera using atomic absorption according to the method
described previously (Shirley et al., 1949). DNA content in
the liver homogenate was estimated using the method of
Dische and Schwarz (1937), which depends on the quantitative
determination of nucleic acids through reacting the sugar com-
ponents of the nucleic acids with diphenyl amine reagent
(DPA).
2.5. Histopathological studies
Liver sections from all groups were ﬁxed in 10% formalin,
embedded in parafﬁn, and dehydrated in ascending concentra-
tions of ethyl alcohol (70–100%). Subsequently, 5-lm tissue
sections were cut, mounted on slides, stained with hematoxylin
and eosin (H&E) for liver histopathology, Masson trichrome
stain for collagen deposition, periodic acid-Schiff (PAS) to
demonstrate glycogen deposition, Mercuric bromophenol blue
for protein detection, and the Feulgen reaction for DNA con-
tent (Drury et al., 1980). The sections were examined using a
Leica DFC 280 light microscope.
2.6. Statistical analysis
Statistical analyses were performed using the GraphPad Prism
software version 4.0 (GraphPad, San Diego, CA). Data are
presented as means with their standard deviation
(mean ± SD). Normality and homogeneity of the data were
conﬁrmed before ANOVA, and differences among the experi-
mental groups were assessed by one-way ANOVA followed by
Tukey’s t-test.
3. Results
3.1. TBARS level, GSH content, and SOD activity
In liver homogenates, no signiﬁcant differences were observed
in the TBARS levels, total GSH content, or SOD activity be-
tween the control group and control + vitamin E group
(P= 0.987, P= 0.995, and P= 0.763, respectively) (Fig. 1).Figure 1 Lipid peroxidation content (TBARS, A), total reduced th
homogenates of all groups. Values were considered signiﬁcantly differe
control group. (a) Signiﬁcantly different when compared with the co
compared with the Cr-treated group. Control + vitamin E represents v
E-treated group. Values are given as mean ± S.D. of six rats in eachHowever, in Cr-affected rats compared with those of the con-
trol group, hepatic TBARS levels were signiﬁcantly higher
(P= 0.0001), whereas the total GSH content and SOD
activity were signiﬁcantly lower (P< 0.0001) (28.7% and
32.4%, respectively) (Fig. 1). Vitamin E administration as a
concomitant dose with K2Cr2O7 resulted in an increase of
25.1% and 28.01% in SOD activity and GSH content, respec-
tively, and in decrease of 14.2% in TBARS levels compared
with the K2Cr2O7-affected group (P< 0.0001) (Fig. 1).
3.2. Serum and hepatic Cr content
It was obvious that the Cr level in both serum and liver
homogenates of the K2Cr2O7-affected rats was signiﬁcantly
higher (P= 0.0023) than Cr level in the control group
(36.79 ± 4.53 ppm/100 ml vs. 21.8 ± 2.67 ppm/100 ml)
(Fig. 2). In the control + vitamin E group, there was no
signiﬁcant difference in the levels of both serum and the
hepatic Cr (P= 0.8793) when compared with the control
group. Vitamin E administration in parallel with K2Cr2O7
to rats failed to reduce the increased levels of Cr in both
serum and liver of the control + vitamin E group when
compared with the Cr group (Fig. 2).
3.3. Nucleic acids (DNA) content
The DNA content (presented as mg/g tissue) in all rat groups
are shown in Fig. 3. Vitamin E administration did not signiﬁ-
cantly affect the hepatic DNA content in the Cr + vitamin E
group compared with the control group (1.03 ± 0.12 mg/g
vs. 1.09 ± 0.09 mg/g). However, signiﬁcant depletion of
DNA content (23.3%, P= 0.0021) was reported in the Cr
group compared with the control group (0.790 ± 0.06 mg/g
vs. 1.09 ± 0.09 mg/g). Vitamin E concomitant treatment with
Cr could ameliorate the decreased DNA content in the liver of
the Cr group compared with the Cr + vitamin E group
(1.02 ± 0.045 mg/g vs. 0.790 ± 0.06 mg/g) (Fig. 2).
3.4. Histopathological ﬁndings
The hepatic parenchyma of the control or vitamin E group had
normal architecture, comprising several hepatic lobulesiol levels (B), and superoxide dismutase activity (C) in the liver
nt at *P< 0.05. *: Signiﬁcantly different when compared with the
ntrol + vitamin E-treated group. (b): signiﬁcantly different when
itamin E-treated group; Cr + vitamin E represents Cr and vitamin
group.
Figure 2 Serum and hepatic Cr levels in all rat groups. Values were considered signiﬁcantly different at P< 0.05. *: Signiﬁcantly
different when compared to control group. (a) Signiﬁcantly different when compared to control + vitamin E-treated group. (b)
Signiﬁcantly different when compared to Cr group. Control + vitamin E represents vitamin E-treated group; Cr + vitamin E represents
Cr and vitamin E-treated group. Values are given as mean ± S.D. of six rats in each group.
Figure 3 Total hepatic DNA content in the control and all
experimental rat groups. Values were considered signiﬁcantly
different at P< 0.05. *: Signiﬁcantly different when compared
with the control group. (a) Signiﬁcantly different when compared
with the control + vitamin E-treated group. (b) Signiﬁcantly
different when compared with the Cr-treated group. Control +
vitamin E represents vitamin E-treated group; Cr + vitamin E
represents Cr and vitamin E-treated group. Values are given as
mean ± S.D. of six rats in each group.
184 A.A. Shatiseparated from each other by very delicate connective tissue
septa housing the portal triad. Each hepatic lobule con-
tained a thin-walled central vein surrounded by hepatic
cords radiating toward the periphery and separated by
blood sinusoids. The hepatocytes appeared polyhedral in
shape with no vacuolated cytoplasm, containing basophilic
granules and central rounded vesicular nuclei (Fig. 4A
and B). Cr-administered rat livers had severe liver damage,
including focal necrosis, congestion of blood vessels, in-
creased lymphocytic inﬁltration around blood vessels, pyk-
notic nuclei, karyolysis, proliferation of Kupffer cells and
bile ductless, and appearance of numerous vacuoles and
sinusoids as well as distortion of hepatic cells (Fig. 4C–
F). These histopathological changes were improved in livers
of the Cr + vitamin E group because the hepatocytes ap-
peared with a normal pattern and the radial arrangement
around the central vein was restored, although congested
blood vessels were still found (Fig. 4G).3.5. Glycogen histochemistry
The livers of the control and vitamin E-treated rat groups re-
vealed that glycogen was observed in the cytoplasm of the
hepatocytes as indicated by the large number of reddish-col-
ored ﬁne granules of different sizes (Fig. 5A and B, respec-
tively) because of strong periodic acid-Schiff (PAS) reaction.
On the other hand, oral Cr administration to rats for consec-
utive 6 weeks resulted in a noticeable decrease in the glycogen
content as evident by the decrease in the amount of PAS-
stained hepatocytes. In these livers, glycogen content displayed
weak intensity of the reaction and became hardly detectable
(Fig. 5C and D). However, combined administration of vita-
min E and Cr strengthened the PAS reaction and resulted in
a large number of reddish-colored ﬁne granules of different
sizes, indicating increased glycogen content that is similar in
intensity to those observed in the control group. The strongest
PAS reaction was in the hepatocytes and around the central
vein (Fig. 5E and F).
3.6. Protein histochemistry
The control or vitamin E group livers were characterized by
high concentrations of total protein content. In cellular cyto-
plasm, the mercury bromophenol blue (Hg–BPB) reaction
was highly positive and was either in the form of bluish
granules of different sizes or in a diffused state, perinuclear
or peripheral in position, particularly concentrated adjacent
to blood sinusoids and equally distributed. In the nucleus,
the chromatic granules and the nucleoplasm were stained
to a less extent and gave a diffused faint blue color
(Fig. 6A and B). Total protein was found to exhibit a notice-
able decrease in cytoplasms and nuclei of the liver cells in
the Cr group because it showed high percentages of pro-
tein-devoid hepatocytes with cytoplasmic vacuolation and
the protein remnants were primarily located on the periphery
of cells, particularly around the central vein (Fig. 6C). How-
ever, oral vitamin E administration concomitant with Cr
could ameliorate changes in protein content in rat livers
when compared with the Cr group. The Hg–BPB reaction in-
creased and dark blue spotted granules of protein of differ-
Figure 4 Hematoxylin and Eosin (H&E) photomicrograph of the liver sections from all rat groups. (A and B) Represent
photomicrograph from the control and control + vitamin E-treated groups, respectively, showing a well-preserved liver architecture
central with central vein (cv) lined with endothelial cells (en), hepatic cells (hp) with centrally located nuclei (n), Kupffer cells (k), and
narrow blood sinusoids (s). (C–F) Represent photomicrograph from Cr-treated rat displaying congested blood vessels (bv) and increased
lymphocytic inﬁltration (l, in) and the distortion of hepatic cells (HP). Pyknotic nuclei (pk), increased Kupffer cells (k), and numerous
vacuoles (v) and sinusoids (s) were also seen. (G and H) Representative photomicrographs from Cr + vitamin E-treated rats showing great
recovery of the hepatocytes (hp). The hepatic cells nearly retain their radial arrangement around the central vein (cv). Numerous sinusoids
(s) appeared between the hepatic cells. The presence of some congested blood vessels (CV) and hemorrhage were observed in some samples.
Ameliorative effect of vitamin E on potassium dichromate-induced hepatotoxicity in rats 185ent sizes or in a diffused state, perinuclear or peripheral in
position, particularly adjacent to blood sinusoids and equally
distributed were seen in the livers of this group of rat
(Fig. 6D and F).
3.7. Feulgen’s reaction
To determine DNA content, liver sections were stained with
Feulgen’s reaction to demonstrate DNA as a magenta color.
Liver sections of the control or vitamin E-treated rat group
showed normal DNA contents (Fig. 7A). The DNA contentwas reduced as explained by moderate magenta color and
faintly stained nuclei in the hepatocytes of liver sections of
the Cr group (Fig. 7B). Liver sections of Cr + vitamin E rats
showed restoration of DNA content similar to that in the con-
trol group (Fig. 7C).
4. Discussion
The present study demonstrated that orally administered vita-
min E could ameliorate hepatic oxidative stress and attenuate
the histopathological damaging effect induced by K2Cr2O7 in
Figure 5 Periodic acid-Schiff (PAS) photomicrograph of the liver sections from all rat groups for detection of glycogen deposition. (A
and B) Represent photomicrograph from the control group and control + vitamin E groups, respectively, showing strong PAS-positive
materials in the hepatocytes (hp). (C and D) Represent photomicrograph from Cr-treated rats showing marked inhibition of PAS-positive
materials in the hepatic cells (hp). Kupffer cells (k), sinusoidal spaces (s), and hemorrhage (h) are abundant. (E and F) Representative
photomicrographs from Cr + vitamin E-treated rats showing great recovery of PAS-positive materials in the liver cells. Glycogen ﬂight
(gf) and numerous sinusoidal spaces (s) are visible. cv: central vein, bv: blood vessels. Red coloration indicates positive PAS reaction.
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effect of vitamin E on glycogen, protein, and DNA content of
hepatocytes. The oxidation state and solubility of Cr com-
pounds determine their toxicity. In contrast to Cr (III), which
is a naturally occurring form and an essential trace element for
humans and others mammals, overdoses of Cr (VI)
compounds are considered highly toxic (Anjum and Shakoori,
1997). K2Cr2O7 is a hexavalent form of Cr and has been
demonstrated to induce oxidative stress and is carcinogenic
in nature (Bagchi et al., 1995). In various studies, it was
suggested that reactive oxygen species (ROS) are involved in
Cr (VI)-induced cell injury (Bagchi et al., 1995; O’Brien
et al., 2001; Ueno et al., 1988). In general, Cr (VI) alone does
not react with DNA in vitro or isolated nuclei (O’Brien et al.,
2001). Within the cell, glutathione (GSH) rapidly forms a
complex with Cr (VI), followed by a slow reduction of Cr
(VI) to yield Cr (V) (O’Brien et al., 2001). In addition to
GSH, a number of in vitro studies have conﬁrmed that various
other substances such as ascorbate, cysteine (Kasprzak, 2002;
O’Brien et al., 2001), lipoic acid, NAD(P)H, fructose, and
ribose (Liu and Shi, 2001), were capable of reducing Cr (VI).
Cr (VI) reduction intermediates [Cr (V) and Cr (IV)] are very
toxic as they involve ROS production (Liu and Shi, 2001). Inthis pathway, once formed Cr (V) can react via the Fenton
reaction with H2O2, forming the hydroxyl radical (OH
) capa-
ble of causing DNA damage and tissue injury (Bagchi et al.,
1997). In addition to the cellular damaging effect of the GSÆ
radical, it can further react with other thiol molecules in
oxygenated tissues to give the superoxide radical. Superoxide
can further reduce Cr (VI)–Cr (V), which can then catalyze
the decomposition of H2O2 thus creating more hydroxyl
radicals. Cr (V) can also be reduced by cellular reductants
(e.g., ascorbate, GSH) to Cr (IV), again participating in
Fenton chemistry generating more hydroxyl radicals. In vivo
experiments have shown that K2Cr2O7 exposition induces
oxidative and nitrosative stress measured as protein carbonyl
content and 3-nitrotyrosine (3-NT) immunostaining (Bagchi
et al., 1997). In the current study, a similar mechanism of Cr
(VI) oxidative stress-mediated hepatotoxicity may apply as
administration of K2Cr2O7 caused a signiﬁcant increase in
MDA level and a signiﬁcant decrease in the GSH level and
SOD activity as markers of oxidative stress and lipid layers
are destroyed. This was conﬁrmed by the damaged liver
architecture in the histopathological ﬁndings. The histopathol-
ogical changes in a liver treated with K2Cr2O7 may be due to
the formation of highly reactive radicals and subsequent lipid
Figure 6 Mercuric bromophenol blue-stained photomicrograph of a liver section from all groups for detection of protein deposition.
Blue coloration indicated positive reaction. (A and B) Represent photomicrographs from the control group and control + vitamin E-
treated groups, respectively, showing dark blue spotted granules of protein stained materials equally distributed in the hepatocytes (hp).
(C) Represents photomicrograph from Cr-treated group and showing a pronounced decrease in protein stained materials of the
hepatocytes (HP). Great loss and unequal distribution of protein stained materials are obvious. (D and E) Represent photomicrographs
from Cr + vitamin E-treated rats showing marked recovery of the hepatocytes (hp) with increase in protein stained material, which is
nearly equally distributed. Bv: blood vessels, s: sinusoidal spaces and v: vacuoles.
Figure 7 Photomicrograph of Feulgen reaction for nuclear DNA detection in the liver sections from all groups (A) represent
photomicrograph from control group displaying an intensive reaction for DNA in the nuclei (n). Kuppfer cells (k) are distinct. (B)
Represents photomicrograph from Cr-treated rat showing great depletion of DNA stained materials in the nuclei (n) of the hepatocytes.
Kupffer cells (k) are markedly increased. (C) Represents: photomicrograph from Cr + vitamin E-treated rats showing the great
restoration of the DNA in the nuclei (n) of the heptocytes. Kupffer cells (k) are still numerous.
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accumulated hydroperoxidase can cause cytotoxicity, which
is associated with the peroxidation of membrane phospholip-
ids by lipid hydroperoxidase, the basis of hepatocellular
damage. These ﬁndings are in agreement with other studies,
which reported that mice treated with cadmium, mercury,
showed signiﬁcant decreases in liver GSH levels due to
decreased antioxidant enzymes, where oxidative stress in
animal tissues may cause oxidative catabolic effects leading
to elevated lipid peroxidation in tissues accompanied withdepletion tissue GSH (Eybl et al., 2006; Fang et al., 2002).
In addition, in line with the ﬁnding of this study, Ercal et al.
(2001) reported enhancement of lipid peroxidation in rat livers
after heavy metal poisoning with mercury, molybdenum,
copper, Cr, and manganese. Moreover, Bagchi et al. (2002)
showed that chromium (VI) induces increase in hepatic
mitochondrial and microsomal lipid peroxidation. In the
current study, the total protein, glycogen, and DNA content
underwent a signiﬁcant depletion in the liver tissue of
K2Cr2O7-treated rats demonstrating the toxic effect of Cr
188 A.A. Shati(VI). Inside the cell, Cr (VI) causes a wide variety of DNA
lesions, including Cr–DNA adducts, DNA–protein crosslinks,
DNA–DNA crosslinks, and direct oxidative stress-mediated
DNA damage (O’Brien et al., 2001). Cr-induced DNA damage
found in this study is in agreement with other studies (Ueno
et al., 2001; Permenter et al., 2011). The decrease in total
protein and glycogen concentration may result due to oxygen
free radical generated by Cr (VI), which oxidizes proteins
and lipoproteins and impairs liver structure and metabolism
(Guzik et al., 2000). The reduction in total protein in animals
exposed to environmental pollutants could be attributed to
changes in protein and free amino acid metabolism, such as
reduced protein synthesis or increased proteolytic activity or
degradation (Yousef et al., 2008). In addition, decreased
protein and glycogen content in response to K2Cr2O7
administration may be contributed to the harmful effect of
its active metabolite. From the histopathological ﬁndings, it
is clear that K2Cr2O7 could decrease total hepatic protein
and glycogen content mainly through its toxic effects on the
liver, either through the necrotic changes, especially of the
plasma membrane, or through inhibiting the oxidative
phosphorylation process and hence the availability of the
energy source for protein synthesis and other metabolic
processes was reported as in previous studies (Guler et al.,
1994). Moreover, it was found that serum and hepatic protein
of rats decreased due to the toxic effect of oxygen free radical
on the thyroid and adrenal glands that leads to block of
protein synthesis, while the fast breakdown occurs. This leads
to an increase in free amino acids and a decrease in protein
turnover (Guler et al., 1994).
Considering the adverse effect of Cr (VI) toxicity on the
liver tissues, preventive intervention is of major concern.
Previous studies have shown that antioxidants’ supplement
could protect the liver tissues from oxidation and prevent
DNA damage under various toxic conditions (Soudani et al.,
2011). Among these chemical agents is vitamin E, which has
drawn wide attention due to its reported hepatoprotective
property against metal-induced toxicity. In this study, oral
treatment of rats with vitamin E resulted in amelioration of
oxidative stress parameters including TBARS levels, GSH
content, and SOD activity. Furthermore, the architectures of
the liver tissues were restored with signiﬁcant improvements
in total hepatic protein, glycogen, and DNA content. Such
protective effects may be related to its antioxidant potential.
Supporting this ﬁnding, Sodergren et al. (2001) concluded that
both nonenzymatic and enzymatic lipid peroxidations during
experimental hepatic oxidative injury were suppressed by
dietary vitamin E supplementation in rats. In addition, the
protective effect of vitamin E on Cr VI-induced cytotoxicity
and lipid peroxidation in primary cultures of rat hepatocytes
was investigated by Susa et al. (1996) where pretreatment of
primary cultures of rat hepatocytes with a-tocopherol
succinate for 20 h prior to exposure to K2Cr2O7 resulted in a
marked decrease of Cr VI-induced cytotoxicity. Supporting
the current study ﬁndings of the protective effect of vitamin
E against Cr (VI)-induced hepatotoxicity, previous studies
have shown a similar protective effect of vitamin E against
many metal-induced hepatotoxicities such as copper, lead
(Al-Attar, 2011; Osfor et al., 2010), aluminum chloride
(Chinoy et al., 2004); cadmium chloride (Gaurav et al., 2010)
and ferrous sulfate (Milchak and Douglas Bricker, 2002).5. Conclusion
The results of this study suggest that oral vitamin E adminis-
tration has a protective effect against Cr (VI)-induced
hepatotoxicity.
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